Producer
Gabriella’s Kitchen Adding Seasoned Executives to Its Board
Gabriella’s Kitchen (CSE: GABY) appears to be on the leading edge to service both mainstream grocery and cannabis distribution channels with CBD infused products, as well as CBD and THC-infused edible and wellness products throughout Canada and the U.S. Positioned to be a strong player in the organic market segment of a burgeoning industry, GABY […]
Canntab & FSD Pharma Make Cannabis More Palatable for Doctors
Cannabinoids have the potential to radically transform the pharmaceutical industry. For example, new studies suggest that cannabis legalization could reduce opioid prescriptions by about six to 12 percent. The problem is that medical cannabis is very different from pharmaceutical drugs—it’s hard for physicians to prescribe treatments that lack consistency or may be metabolized differently between […]
Pascal Biosciences Provides Year-End Investor Update and Reviews Upcoming Milestones
– 2018 pipeline expansion includes lead cannabinoid-based cancer therapeutic – Clinical trial in glioblastoma to begin in 2019 VANCOUVER, British Columbia and SEATTLE, Dec. 20, 2018 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced a year-end review of accomplishments during 2018 and insight into plans […]
High Hampton’s Mojave Jane Announces Start Of Production In California January 2019
TORONTO, Dec. 19, 2018 CSE: HC OTC: HHPHF FSE: 0HCN Toronto, ON – High Hampton Holdings Corp. (CSE: HC) (FSE: 0HCN) (“High Hampton” or the “Company”) is pleased to announce that its fully owned subsidiary Mojave Jane LLC (“Mojave Jane”) is set to commence full scale production in the City of Coachella, California, in January […]
Creso Pharma Brings Together Cannabis Experts Across Several Verticals
The due diligence process looks very different for small-cap versus large-cap stocks. When analyzing large-cap companies, investors pay closest attention to financial statements and valuation ratios to extrapolate growth rates and apply multiples. Small-cap stocks tend to be earlier stage companies without an established earnings track record, which means that investors must consider the management […]
NanoSphere Closes $1.335M First Tranche of Private Placement
DENVER–(BUSINESS WIRE)–NanoSphere Health Sciences Inc. (CSE: NSHS) (OTC: NSHSF) the biotechnology leader behind the patented NanoSphere Delivery System™, is pleased to announce a first tranche closing of its non-brokered private placement announced November 28, 2018. Pursuant to the first tranche, the company issued 4,452,254 Units at a price of $0.30 per Unit for gross proceeds […]
How California Can Overcome Its Cannabis Challenges
California’s cannabis industry is projected to reach $5.1 billion by the end of 2019, according to BDS Analytics, but unexpected challenges have slowed progress. These challenges range from excessive regulations to sky-high taxation. Investors looking for opportunities in the state may want to look at companies that are actually working to solve these challenges rather […]
Sales amendment granted for Highland Grow—Amendment to License Significantly Increases Product Availability for Medical and Adult Consumer-Use Markets Toronto, Ontario (December 17th, 2018) – Biome Grow Inc. (“Biome” or the “Company”) (CSE: BIO) (Frankfurt: 6OTA) (OTC: ORTFF) is pleased to announce its Nova Scotia-based subsidiary, Highland Grow Inc. (“Highland Grow”), has received its sales authorization […]
Canntab Partners with Leading Surgeon to Conduct Pain Management Trial
The opioid industry is expected to generate nearly $20 billion in annual revenue by 2020, but the addictive nature of the drug has doctors and patients increasingly concerned. With the legalization of cannabis across Canada and many U.S. states, there’s an opportunity to replace dangerous opioids with efficacious cannabinoids to treat chronic and acute pain. […]
Blockchain Technology Offers a Solution to Cannabis Quality Control
The Canadian cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, following the legalization of adult-use cannabis earlier this year. While early sales have been brisk, the industry faces key challenges with safety and quality control. Many consumers still receive the wrong strains, while companies continue to struggle to […]
Aleafia Health: A New LP with 22 Medical Clinics, 50K Patients and 98,000 kg Production
The Canadian cannabis market is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of adult-use cannabis nationwide. While many companies are focused on supplying the recreational market, the medical market may continue to offer the best source of higher margin recurring income. Many successful LPs are also […]
From The Ground Up: City View Green Is Building A Winning Cannabis Strategy Piece By Piece
The Canadian cannabis industry is ripe with targets for mergers and acquisitions. For Rob Fia, CEO of Icon Exploration (TSX-V- IEX), which is completing a reverse takeover of private company City View Green (CVG), the idea of building a state-of-the art cannabis company from the ground up offered a better value proposition. In just over […]
Icon Exploration Inc. Discusses its Cannabis Strategy in Exclusive NetworkNewsWire Audio Interview
NEW YORK, Dec. 12, 2018 (GLOBE NEWSWIRE) — via NetworkNewsAudio – NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) Solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community, today announces the online availability of its interview with Icon Exploration Inc. (TSX.V: IEX.H), a client of NNW currently focused on assessing potential acquisition targets […]
Grown Rogue Moves into California’s $5 Billion Cannabis Market
California’s cannabis industry is the largest in the country with revenue expected to reach $5.1 billion by 2022, according to Arcview Market Research and BDS Analytics. With about 40 million residents and a long history of cannabis usage, the state presently represents about a third of the North American cannabis market. The legalization of recreational […]
Pascal Biosciences Announces Year-End Investor Update Webcast
Advancement of Cannabinoid Cancer Programs and Corporate Review to be Presented Scheduled for Dec. 17, 2018 at 1:30 p.m. Pacific VANCOUVER, British Columbia and SEATTLE, Dec. 10, 2018 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, announced today it will host a year-end investor update webcast […]
Lexaria Bioscience Expands Staff, Issues Options
(via TheNewswire) Kelowna, British Columbia / TheNewswire / December 7, 2018 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces the following updates. The Company continues to hire additional personnel including a new corporate controller; head of legal division and other office staff. In the New […]
NanoSphere Forms Strategic Partnership to Launch Evolve Products in Mexico
VANCOUVER, British Columbia Agreement will bring the patented NanoSphere Delivery System™ to an emerging $5 billion cannabis market NanoSphere Health Sciences Inc. (CSE:NSHS) (OTC:NSHSF) (“NanoSphere” or “the Company”), the biotechnology leader behind the patented NanoSphere Delivery System™, is pleased to announce the Company has signed a Letter of Intent forming a partnership with Abba Import […]
Grown Rogue Wins Highest THC % and Highest Terpenes % at Grow Classic
MEDFORD, OR, USA, December 7, 2018 /EINPresswire.com/ — Grown Rogue took home top honors from the Grow Classic held in Eugene, OR last weekend. The company was one of 31 elite growers from across the state of Oregon who entered the three-category competition, in which Grown Rogue took first place for Highest THC %, first […]
Partnership formed with Dr. Don Garbuz, an award winning orthopaedic surgeon and medical researcher, credited with over 120 peer reviewed publications. The parties will seek to conduct a clinical study with orthopaedic patients, using Canntab’s sustained release tablets. The study aims to show the potential for reduction or elimination of the use of opiates in […]
Supreme Cannabis Focused on Disciplined Deployment of Capital
The cannabis industry has boomed in recent years supported by the access to inexpensive capital, which has stemmed from a voracious investor appetite for cannabis exposure and the prospects of outsized returns. In turn, many licensed producers have quickly deployed any raised capital to feed the investor frenzy and the demand for growth prospects and […]
MedMen Expanding Across the US Legal Cannabis Markets
The recent elections brought the total number of states allowing some form of legalized cannabis to 33, with Michigan expanding its medical program to full adult use legalization and both Utah and Missouri voting for regulated medical programs. The legal U.S. cannabis market is steadily growing, making it the largest legal cannabis market in the […]
FSD Pharma Adds David Urban to Board Of Directors
TORONTO – November 14, 2018 – FSD Pharma Inc. (“FSD Pharma” or the “Company”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) announced today the appointment of David Urban to the Company’s Board of Directors. Mr. Urban is an accomplished business and government relations executive. He advises companies ranging in size from start-ups to the Fortune 100 […]
TORONTO, Nov. 13, 2018 (GLOBE NEWSWIRE) — Today, New Green Frontier, an invite-only, cannabis investor conference, is pleased to announce that Gene Simmons, legendary rock star, Chief Evangelist Officer of Invictus-MD (TSXV: GENE, OTC: IVITF) will be the keynote speaker for this year’s inaugural event. The event is happening November 19, 2018 in Toronto, ON, […]
High Hampton Closes Acquisition of Mojave Jane, Licensed California Cannabis Manufacturing Company
Acquisition adds near-term revenue and creates notable benefits through synergies within High Hampton’s growing portfolio of subsidiaries TORONTO, Nov. 12, 2018 /CNW/ – High Hampton Holdings Corp. (CSE: HC) (FSE: 0HCN) (“High Hampton” or the “Company“) is pleased to report that it has successfully closed the previously announced transaction to acquire 100% of all of […]
48North Cannabis Corp. Acquires Good & Green for Next Generation Cannabis Products
In late October of this 2018, 48North Cannabis Corp. (TSX-V: NRTH) entered into a binding letter agreement to acquire all issued and outstanding common shares of privately-held Good & Green, a socially-responsible, organic cannabis brand. Combined with a variety of vertically integrated partnerships, investors are keen to watch the movement of 48North as it […]
48North Cannabis Corp. Announces Transformational Acquisition and $10MM Private Placement
TORONTO, Oct. 30, 2018 /CNW/ – 48North Cannabis Corp. (“48North” or the “Company”) (TSXV:NRTH) and 2599708 Ontario Inc. (“Good & Green”) have entered into a letter agreement that became binding on October 29, 2018, whereby 48North will acquire all of the issued and outstanding common shares of privately-held Good & Green in an all-share transaction valued […]
FSD Pharma Doubles Down on Cannabinoid Therapeutics with Therapix Acquisition
Canada’s cannabis industry could experience a dramatic windfall with the legalization of recreational cannabis in October, but many cannabis companies are looking beyond the borders for opportunities. In particular, the most progressive cannabis companies are building up both their medical and recreational cannabis footprints, while expanding their production capacity to meet growing global demand over […]
Canntab Files Application to Become Licensed Producer
TORONTO, Oct. 19, 2018 (GLOBE NEWSWIRE) — Canntab Therapeutics Limited (CSE:PILL) (“Canntab” or the “Company”), a leader in the development of precision oral dose cannabis tablets and capsules, is pleased to announce that it has filed an application to become a Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (the “License”), and […]
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Alan Brochstein’s 420 Investor is the go-to community for investors to learn, explore, and profit from the marijuana companies. The main goal of 420 Investor is to provide real-time, objective information about the top marijuana companies in the market in order to help investors capitalize on cannabis.
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
Revive Therapeutics’ cannabinoid pharmaceutical portfolio focuses on rare inflammatory areas such as liver disease.
Zenabis owns 660,000 square feet of high quality indoor facility space, as well as 2.1 million square feet of greenhouse space that will be dedicated to cannabis production once fully built-out.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
